Ebselen augments its peroxidase activity by inducing nrf-2-dependent transcription

V. Tamási, Julianne M. Jeffries, Gavin E. Arteel, K. Cameron Falkner

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Ebselen is an organoselenium compound that acts as a glutathione peroxidase mimic. Since ebselen is a hydrophobic, thio-reactive compound capable of interacting with Keap-1, we tested its ability to activate nrf-2-dependent responses in the human hepatocarcinoma derived cell line, HepG2. Ebselen (25 μM) increased expression of an nrf-2 response element reporter in transient transfection experiments by 4-fold. Although, the induction was lower than that observed with classic nrf-2 inducer, sulforaphane (10 μL; 7-fold), ebselen also induced expression of native NAD(P)H:quinone oxidoreductase (1.6-fold) activity; induction of this protein is known to be dependent on nrf-2 action. Treatment of HepG2 cells with ebselen increased glutathione levels after 12 (1.5-fold) or 24 (1.9-fold) h of treatment. Treatment of the cells with either sulforaphane or ebselen 24 h prior to treatment with varying concentrations of t-butyl hydroperoxide increased the half maximal lethal dose from 28 to 42μM and 58 μM for sulforaphane and ebselen, respectively. The protective effects of ebselen treatment were greater with pretreatment (IC 50 = 58 μM) than simultaneous addition (IC 50 = 45 μM). The protein synthesis inhibitor cycloheximide blocked increases in intracellular glutathione synthesis and partially blocked the protective effects of this regimen on increasing cell survival following t-butyl hydroperoxide treatment. Likewise co-treatment with the MEK 1 inhibitor, PD98059, which has been shown to inhibit nrf-2-dependent gene activation, partially inhibited the ebselen-dependent increases in IC 50 while not affecting the control cells. We conclude that nrf-2 activation augments the role of ebselen as an antioxidant or by indirect induction of cellular antioxidant defences.

Original languageEnglish
Pages (from-to)161-168
Number of pages8
JournalArchives of Biochemistry and Biophysics
Volume431
Issue number2
DOIs
Publication statusPublished - Nov 15 2004

Fingerprint

Transcription
Peroxidase
tert-Butylhydroperoxide
Cells
Glutathione
Organoselenium Compounds
Antioxidants
Chemical activation
ebselen
Protein Synthesis Inhibitors
Mitogen-Activated Protein Kinase Kinases
Hep G2 Cells
Response Elements
Cycloheximide
Glutathione Peroxidase
NAD
Transcriptional Activation
Transfection
Cell Survival
Oxidoreductases

Keywords

  • Antioxidant response
  • Ebselen
  • Glutathione
  • nrf-2
  • t-Butyl hydroperoxide

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Ebselen augments its peroxidase activity by inducing nrf-2-dependent transcription. / Tamási, V.; Jeffries, Julianne M.; Arteel, Gavin E.; Falkner, K. Cameron.

In: Archives of Biochemistry and Biophysics, Vol. 431, No. 2, 15.11.2004, p. 161-168.

Research output: Contribution to journalArticle

Tamási, V. ; Jeffries, Julianne M. ; Arteel, Gavin E. ; Falkner, K. Cameron. / Ebselen augments its peroxidase activity by inducing nrf-2-dependent transcription. In: Archives of Biochemistry and Biophysics. 2004 ; Vol. 431, No. 2. pp. 161-168.
@article{dd2dac2a53b44528aa404a4a525fac47,
title = "Ebselen augments its peroxidase activity by inducing nrf-2-dependent transcription",
abstract = "Ebselen is an organoselenium compound that acts as a glutathione peroxidase mimic. Since ebselen is a hydrophobic, thio-reactive compound capable of interacting with Keap-1, we tested its ability to activate nrf-2-dependent responses in the human hepatocarcinoma derived cell line, HepG2. Ebselen (25 μM) increased expression of an nrf-2 response element reporter in transient transfection experiments by 4-fold. Although, the induction was lower than that observed with classic nrf-2 inducer, sulforaphane (10 μL; 7-fold), ebselen also induced expression of native NAD(P)H:quinone oxidoreductase (1.6-fold) activity; induction of this protein is known to be dependent on nrf-2 action. Treatment of HepG2 cells with ebselen increased glutathione levels after 12 (1.5-fold) or 24 (1.9-fold) h of treatment. Treatment of the cells with either sulforaphane or ebselen 24 h prior to treatment with varying concentrations of t-butyl hydroperoxide increased the half maximal lethal dose from 28 to 42μM and 58 μM for sulforaphane and ebselen, respectively. The protective effects of ebselen treatment were greater with pretreatment (IC 50 = 58 μM) than simultaneous addition (IC 50 = 45 μM). The protein synthesis inhibitor cycloheximide blocked increases in intracellular glutathione synthesis and partially blocked the protective effects of this regimen on increasing cell survival following t-butyl hydroperoxide treatment. Likewise co-treatment with the MEK 1 inhibitor, PD98059, which has been shown to inhibit nrf-2-dependent gene activation, partially inhibited the ebselen-dependent increases in IC 50 while not affecting the control cells. We conclude that nrf-2 activation augments the role of ebselen as an antioxidant or by indirect induction of cellular antioxidant defences.",
keywords = "Antioxidant response, Ebselen, Glutathione, nrf-2, t-Butyl hydroperoxide",
author = "V. Tam{\'a}si and Jeffries, {Julianne M.} and Arteel, {Gavin E.} and Falkner, {K. Cameron}",
year = "2004",
month = "11",
day = "15",
doi = "10.1016/j.abb.2004.07.030",
language = "English",
volume = "431",
pages = "161--168",
journal = "Archives of Biochemistry and Biophysics",
issn = "0003-9861",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Ebselen augments its peroxidase activity by inducing nrf-2-dependent transcription

AU - Tamási, V.

AU - Jeffries, Julianne M.

AU - Arteel, Gavin E.

AU - Falkner, K. Cameron

PY - 2004/11/15

Y1 - 2004/11/15

N2 - Ebselen is an organoselenium compound that acts as a glutathione peroxidase mimic. Since ebselen is a hydrophobic, thio-reactive compound capable of interacting with Keap-1, we tested its ability to activate nrf-2-dependent responses in the human hepatocarcinoma derived cell line, HepG2. Ebselen (25 μM) increased expression of an nrf-2 response element reporter in transient transfection experiments by 4-fold. Although, the induction was lower than that observed with classic nrf-2 inducer, sulforaphane (10 μL; 7-fold), ebselen also induced expression of native NAD(P)H:quinone oxidoreductase (1.6-fold) activity; induction of this protein is known to be dependent on nrf-2 action. Treatment of HepG2 cells with ebselen increased glutathione levels after 12 (1.5-fold) or 24 (1.9-fold) h of treatment. Treatment of the cells with either sulforaphane or ebselen 24 h prior to treatment with varying concentrations of t-butyl hydroperoxide increased the half maximal lethal dose from 28 to 42μM and 58 μM for sulforaphane and ebselen, respectively. The protective effects of ebselen treatment were greater with pretreatment (IC 50 = 58 μM) than simultaneous addition (IC 50 = 45 μM). The protein synthesis inhibitor cycloheximide blocked increases in intracellular glutathione synthesis and partially blocked the protective effects of this regimen on increasing cell survival following t-butyl hydroperoxide treatment. Likewise co-treatment with the MEK 1 inhibitor, PD98059, which has been shown to inhibit nrf-2-dependent gene activation, partially inhibited the ebselen-dependent increases in IC 50 while not affecting the control cells. We conclude that nrf-2 activation augments the role of ebselen as an antioxidant or by indirect induction of cellular antioxidant defences.

AB - Ebselen is an organoselenium compound that acts as a glutathione peroxidase mimic. Since ebselen is a hydrophobic, thio-reactive compound capable of interacting with Keap-1, we tested its ability to activate nrf-2-dependent responses in the human hepatocarcinoma derived cell line, HepG2. Ebselen (25 μM) increased expression of an nrf-2 response element reporter in transient transfection experiments by 4-fold. Although, the induction was lower than that observed with classic nrf-2 inducer, sulforaphane (10 μL; 7-fold), ebselen also induced expression of native NAD(P)H:quinone oxidoreductase (1.6-fold) activity; induction of this protein is known to be dependent on nrf-2 action. Treatment of HepG2 cells with ebselen increased glutathione levels after 12 (1.5-fold) or 24 (1.9-fold) h of treatment. Treatment of the cells with either sulforaphane or ebselen 24 h prior to treatment with varying concentrations of t-butyl hydroperoxide increased the half maximal lethal dose from 28 to 42μM and 58 μM for sulforaphane and ebselen, respectively. The protective effects of ebselen treatment were greater with pretreatment (IC 50 = 58 μM) than simultaneous addition (IC 50 = 45 μM). The protein synthesis inhibitor cycloheximide blocked increases in intracellular glutathione synthesis and partially blocked the protective effects of this regimen on increasing cell survival following t-butyl hydroperoxide treatment. Likewise co-treatment with the MEK 1 inhibitor, PD98059, which has been shown to inhibit nrf-2-dependent gene activation, partially inhibited the ebselen-dependent increases in IC 50 while not affecting the control cells. We conclude that nrf-2 activation augments the role of ebselen as an antioxidant or by indirect induction of cellular antioxidant defences.

KW - Antioxidant response

KW - Ebselen

KW - Glutathione

KW - nrf-2

KW - t-Butyl hydroperoxide

UR - http://www.scopus.com/inward/record.url?scp=5644257028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5644257028&partnerID=8YFLogxK

U2 - 10.1016/j.abb.2004.07.030

DO - 10.1016/j.abb.2004.07.030

M3 - Article

VL - 431

SP - 161

EP - 168

JO - Archives of Biochemistry and Biophysics

JF - Archives of Biochemistry and Biophysics

SN - 0003-9861

IS - 2

ER -